Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	70.77	333.52	195.30
Graham Fair Price	-56.97	7.71	17.92
PEG	942.41	-7.28	0.70
Price/Book	21.85	5.19	4.26
Price/Cash Flow	-21.77	770.06	984.36
Prices/Earnings	564.38	593.20	89.29
Price/Sales	38.07	53.33	38.62
Price/FCF	-21.77	770.06	984.36
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-16.07	0.40	0.47
Operating Margin	-79.57	0.01	0.06
ROA	-81.56	< 0.005	< 0.005
ROE	0.01	< 0.005	-81.66
ROIC	0.01	< 0.005	-81.83
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.05	-96.62
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.53	-0.82	55.42
EPS QOQ	1.28	-0.81	-36.27
FCF QOQ	-0.19	0.57	205.70
Revenue QOQ	0.06	-0.11	77.59
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	120.23	126.68	5.37
Days Sales Outstanding (DSO)	78.57	83.36	6.09
Inventory Turnover	0.75	0.71	-5.09
Debt/Capitalization	0.05	0.04	-17.49
Quick Ratio	1.67	1.72	2.82
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	34.59	34.75	0.49
Cash	3.57	3.73	4.47
Capex	-0.09	-0.09	-2.10
Free Cash Flow	0.15	0.23	56.51
Revenue	3.82	3.38	-11.32
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.51	2.64	5.27
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-0.77	-1.18	-53.72
Naive Interpretation	Member

06 - Financial Health · Bad

Rating